VENTANA PD-L1(SP142) Assay Testing Sites UC

VENTANA PD-L1(SP142) Assay

Delivering confidence to appropriately identify urothelial carcinoma (UC) patients most likely to benefit from TECENTRIQ™ (atezolizumab)

  • FDA approved to predict UC patient response to TECENTRIQ™
  • Evaluate PD-L1 status with immune cell interpretation and scoring
  • Designed to enhance visual contrast of immune cell staining within the tumor microenvironment

Test Centers

Aurora Diagnostics LMC Pathology Services

T7455 W. Washington Avenue, Suite 301
Las Vegas, NV 89128
Phone: 877-LMC-LABS
Phone: 702-732-3441
Fax: 702-732-2310
www.auroradxlmc.com

Cancer Genetics Inc.

201 Route 17 North, Meadows Office Bldg.
Rutherford, NJ 07070
Phone: 201-528-9200
www.cancergenetics.com

Caris Life Sciences

4610 South 44th Place, Phoenix, AZ 85040
Phone: 602.464.7500
Web: www.CarisLifeSciences.com

Integrated Oncology

www.integratedoncology.com
Arizona
Phone: 800-710-1800
Fax: 800-481-4151
New York
Phone: 800-447-5861
Fax: 212-258-2143
Tennesee
Phone: 800-874-8532
Fax: 615-370-8074

Laboratory Corporation of America

www.labcorp.com
Phone: 800-345-GENE (4363)
Fax: 888-287-8199
1904 Alexander Drive
Research Triangle Park, NC 27709

Mayo Clinic Laboratories

3050 Superior Drive NW
Rochester, MN 55901
1-800-533-1710
www.mayocliniclabs.com

NeoGenomics Laboratories

31 Columbia
Aliso Viejo, CA 92656
Phone: 888-443-3311
www.neogenomics.com

PhenoPath Laboratories

551 North 34th St, Suite 100
Seattle WA 98103
Phone: 206-374-9000
Fax: 206-374-9009
www.phenopath.com/

Providence Regional Laboratory Services

Test Code: PD-L1
4400 NE Halsey St
Portland, OR 97213
Phone: 503-893-7777
www.providence.org

Quest Diagnostics Nichols Institute

33608 Ortega Highway
San Juan Capistrano, CA 92690 USA
Phone: 949-728-4879
Fax: 949-728-4992
www.nicholsinstitute.com

Thomas Jefferson University Hospitals, Inc.

Test Code: PDL1 UC
132 S. 10th Street, Room 283 Main Bldg.
Philadelphia, PA 19107
Phone: 215-955-6352
www.jefferson.edu

If you would like your lab featured on this list, please opt in here.